Monographie - Rifampicin - Stabilis 4.0

Last update :
29/10/2024

Antibiotic

Rifampicin

injection

Oral solution

Stability in solutions

Stability of mixtures

Factors which affect stability

Compatibility

Route of administration

References

pdf

Chemical structure

Tradename

Tradename

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Eremfat	Austria, Germany
Rif	Turkey
Rifa	Germany
Rifadin	Australia, Great Britain, Iran, Ireland, Italy, Netherlands, New Zealand, Sweden, United States of America
Rifadine	Belgium, France, Morocco
Rifaldin	Iran, Spain
Rifampicin	Germany
Rifampicina	Argentina, Ecuador
Rifampin	United States of America
Rifoldin	Austria
Rimactan	Switzerland
Rimactane	Ireland

References

injection

References : Rifampicin

	Type	Publication
198	Journal	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
263	Journal	Pearson SD, Trissel LA. Stability and compatibility of minocycline hydrochloride and rifampicin in intravenous solutions at various temperatures. Am J Hosp Pharm 1993 ; 50: 698-702.
2139	Journal	Serrurier C, Chenot ED, Vigneron J, May I, Demor? B. Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. EJHP Science 2006 ; 12,5: 96-99.
3379	Journal	Fox L.M, Wilder A.G, Foushee J.A. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration. Am J Health-Syst Pharm 2013 ;70:520-524.
3541	Manufacturer	Rifampicin (Rifadin®) – Summary of Product Characteristics Sanofi 2011
4405	Journal	Ezquer-Garin C, Ferriols-Lisart R, Martinez-López LM, Sangrador-Pelluz C, Nicolás-Picó J, Alós-Almiñana M. Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures Pharmazie 2020 ; 75: 172-176.
4543	Journal	Senarathna G, Strunk T, Petrovski M, Batty K. Physical compatibility of pentoxifylline and intravenous medications. Archives of Disease in Childhood 2018 ;104:292–295.
4837	Journal	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales